Medicine and Dentistry
Brain Tissue
20%
Cell Growth
20%
Clinical Study
20%
Cytotoxic Agent
20%
Ependymoma
100%
Ganglioglioma
100%
Gene Expression Profiling
20%
Glioma Cell Line
20%
Growth Inhibition
20%
IC50
20%
Intracranial Tumor
20%
Malignant Neoplasm
20%
Medulloblastoma
100%
Monotherapy
20%
Neoplasm
40%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
20%
Olaparib
60%
PARP Inhibitor
80%
PARP1
40%
Pediatrics
20%
Poly ADP Ribose Polymerase
100%
Protein Expression
20%
Radiation Therapy
40%
Sensitization
20%
Tumor Cell
20%
Keyphrases
Brain Tissue
14%
Cell Growth Inhibition
14%
Childhood Medulloblastoma
14%
Cytotoxic Agents
14%
Differential Sensitivity
14%
DNA Damage
14%
Double-strand Break Repair
14%
Double-strand Breaks
14%
Ependymoma
100%
Gene Expression Profiling
14%
Glioma Cell Lines
14%
Growth Inhibition Assay
14%
High-grade Brain Tumor
14%
High-grade Glioma
100%
IC50 Value
14%
Medulloblastoma
100%
Monotherapy
14%
Non-neoplastic
14%
Olaparib
42%
PARP Inhibitor (PARPi)
100%
Pediatric Glioma
14%
Poly (ADP-ribose) Polymerase Inhibition
100%
Poly(ADP-ribose) Polymerase
14%
Poor Prognosis
14%
Protein Expression
14%
Radiosensitization
14%
Radiotherapy
28%
Repair Pathway
14%
Single-strand Break Repair
14%
Synthetic Lethal
14%
Therapeutic Outcome
14%
Tumor
14%
Tumor Cells
14%
Tumor Subtype
14%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Study
20%
Cytotoxic Agent
20%
Ependymoma
100%
Glioma
100%
IC50
20%
Intracranial Tumor
20%
Malignant Neoplasm
20%
Medulloblastoma
100%
Monotherapy
20%
Neoplasm
60%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
20%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
80%
Olaparib
60%
Neuroscience
Cell Growth
20%
Cell Line
20%
Ependymoma
100%
Gene Expression
20%
Intracranial Tumor
20%
Medulloblastoma
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
20%
Olaparib
60%
PARP Inhibitor
80%
Poly ADP Ribose Polymerase
100%
Protein Expression
20%
Radiation Therapy
40%